Case Reports
doi: 10.1684/epd.2011.0406.
Treatment of malignant migrating partial epilepsy of infancy with rufinamide: report of five cases
Affiliations
- PMID: 21393094
- DOI: 10.1684/epd.2011.0406
Item in Clipboard
Case Reports
Treatment of malignant migrating partial epilepsy of infancy with rufinamide: report of five cases
Epileptic Disord.
2011 Mar.
Free article
Abstract
The syndrome of malignant migrating partial seizures of infancy (MMPEI) is characterized by early onset of multiple seizures types, highly pharmaco-resistant seizures, and overall poor prognosis. In this study, we investigated retrospectively the efficacy of rufinamide (RUF) in five infants with MMPEI, by examining seizure type and frequency, EEG features and antiepileptic drug use. The data demonstrate that two of the five patients showed good efficacy and tolerability for RUF with a > 50% reduction in seizure frequency. The use of RUF for the treatment of MMPEI may therefore provide some hope for such infants and should be further validated. [Published with video sequences].
Similar articles
-
Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.Epilepsy Behav. 2009 Mar;14(3):491-5. doi: 10.1016/j.yebeh.2008.12.013. Epub 2009 Jan 20. Epilepsy Behav. 2009. PMID: 19162229
-
Rufinamide: a new antiepileptic medication for the treatment of seizures associated with lennox-gastaut syndrome.Ann Pharmacother. 2010 Apr;44(4):658-67. doi: 10.1345/aph.1M679. Epub 2010 Mar 16. Ann Pharmacother. 2010. PMID: 20233912 Review.
-
Experience with rufinamide in a pediatric population: a single center's experience.Pediatr Neurol. 2010 Sep;43(3):155-8. doi: 10.1016/j.pediatrneurol.2010.04.003. Pediatr Neurol. 2010. PMID: 20691934
-
Malignant migrating partial seizures of infancy controlled by stiripentol and clonazepam.Brain Dev. 2013 Feb;35(2):177-80. doi: 10.1016/j.braindev.2012.03.016. Epub 2012 Apr 20. Brain Dev. 2013. PMID: 22521903
-
Rufinamide for refractory epilepsy in a pediatric and young adult population.Epilepsy Res. 2011 Jan;93(1):87-9. doi: 10.1016/j.eplepsyres.2010.10.017. Epub 2010 Dec 15. Epilepsy Res. 2011. PMID: 21111576 Review.
Cited by
-
Efficacy of anti-seizure medications and alternative therapies (ketogenic diet, CBD, and quinidine) in KCNT1-related epilepsy: A systematic review.Epilepsia Open. 2024 Aug;9(4):1176-1191. doi: 10.1002/epi4.12975. Epub 2024 Jun 22. Epilepsia Open. 2024. PMID: 39093319 Free PMC article. Review.
-
Migrating partial seizures of infancy: expansion of the electroclinical, radiological and pathological disease spectrum.Brain. 2013 May;136(Pt 5):1578-91. doi: 10.1093/brain/awt073. Epub 2013 Apr 18. Brain. 2013. PMID: 23599387 Free PMC article.
-
Update on rufinamide in childhood epilepsy.Neuropsychiatr Dis Treat. 2011;7:399-407. doi: 10.2147/NDT.S13910. Epub 2011 Jul 5. Neuropsychiatr Dis Treat. 2011. PMID: 21792306 Free PMC article.
-
De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy.Nat Genet. 2012 Nov;44(11):1255-9. doi: 10.1038/ng.2441. Epub 2012 Oct 21. Nat Genet. 2012. PMID: 23086397 Free PMC article.
-
Network for Therapy in Rare Epilepsies (NETRE): Lessons From the Past 15 Years.Front Neurol. 2021 Jan 14;11:622510. doi: 10.3389/fneur.2020.622510. eCollection 2020. Front Neurol. 2021. PMID: 33519703 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
